Top clipped slide. Download Now Download Download to read offline. Atp iv. Manual amir endocrinologia. Resumen atp iv 1. New fundamentals in hemostasis. Sistema de coagulacion. Clase parasitosis Related Books Free with a 30 day trial from Scribd.
Jen Gunter. Related Audiobooks Free with a 30 day trial from Scribd. Gundry, MD. Permission to Dream Chris Gardner. Single On Purpose: Redefine Everything. Find Yourself First. John Kim. Factores de Riesgo Mayores. Coronaria EC temprana. Causas de dislipidemia secundaria. Terapia reductora de LDL en pacientes con factores de riesgo. Cambios en el estilo de vida en el tratamiento reductor de LDL. Sandra Del Rio Romero Aug.
Rossy Cruz Romero Jun. Show More. Total views. You just clipped your first slide! Eur Heart J, 19 , pp. Atherogenicity of triglyceride-rich lipoproteins. Seman, C. DeLuca, J. Jenner, L. Cupples, J. McNamara, P. Wilson, et al.
Lipoprotein a -cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 45 , pp. Danesh, R. Collins, R. Lipoprotein a and coronary heart disease. Meta-analysis of prospective studies. Circulation, , pp. Moliterno, E. Jokinen, A. Miserez, R. Lange, J. Willard, E. Boerwinkle, et al. No association between plasma lipoprotein a concentrations and the presence or absence of coronary atherosclerosis in African-Americans.
Arterioscler Thromb Vasc Biol, 15 , pp. Tornvall, P. Bavenholm, C. Landou, U. De Faire, A. Relation of plasma levels and composition of apolipoprotein Bcontaining lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
Circulation, 88 , pp. Montalescot, J. Collet, R. Choussat, D. Fibrinogen as a risk factor for coronary heart disease. Wiman, T.
Andersson, J. Hallqvist, C. Reuterwall, A. Ahlbom, U. De Faire. Arterioscler Thromb Vasc Biol, 20 , pp. Moss, R. Goldstein, V. Marder, C. Sparks, D. Oakes, H. Greenberg, et al. Thrombogenic factors and recurrent coronary events. Circulation, 99 , pp. Hackman, S. Emerging risk factors for atherosclerotic vascular disease.
A critical review of evidence. Heeschen, S. Dimmeler, C. Hamm, M. Van den Brand, E. Boersma, A. Zeiher, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med, , pp. Varo, J. De Lemos, P. Libby, D. Morrow, S. Murphy, R.
Nuzzo, et al. Soluble CD40L. Risk prediction after acute coronary syndromes. Ridker, C. Hennekens, J. Buring, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. Koenig, M. Sund, M. Frohlich, H. Fischer, H. Lowel, A. Doring, et al. C-reactive protein, a sensitive marker of inflammation, predicts furture risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA monitoring trends and determinants in cardiovascular disease Augsburg cohort study, to Grundy, M.
Dietary influences on serum lipids and lipoproteins. J Lipid Res, 31 , pp. Mensink, M. Effects of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioescler Thromb, 12 , pp. Kris-Etherton, S. Individual fatty acids effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr, 65 , pp.
El colesterol de la dieta y su escasa influencia sobre la colesterolemia y el riesgo cardiovascular. Clin Invest Arterioscler, 12 , pp. Lichtenstein, L. Ausman, S. Jalbert, E. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. Ascherio, M. Katan, P. Zock, M. Stampfer, W. Assorted monounsaturated fatty acids promote healthy hearts.
Am J Clin Nutr, 70 , pp. Ascherio, E. Rimm, M. Stampfer, E. Giovanucci, W. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. Nut consumption, lipids and risk of a coronary event.
Clin Cardiol, 22 , pp. De Lorgeril, S. Renaud, N. Mamelle, P. Salen, J. Martin, I. Monjaud, et al. Mediterranean alpha-linoleic acid-rich diet in secondary prevention of coronary heart disease. Lancet, , pp. Vivekananthan, M.
Penn, S. Sapp, A. Hsu, E. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
Morris, S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the US. Ann Intern Med, , pp. Venn, J. Mann, S. Williams, L. Riddell, A. Chisholm, M. Harper, et al. Dietary counseling to increase natural folate intake: a randomized, placebo-controlled trial in free-living subjects to assess effects on serum folate and plasma total homocysteine.
Am J Clin Nutr, 76 , pp. Wald, M. Law, J. Homocysteine and cardiovascular disease: evidence on causality from a meta—analysis. BMJ, , pp. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults —the evidence report. Obes Res, 6 , pp. Eckel, R. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation, 97 , pp. Rajala, P. The adipocyte at the cossroads of energy homoestasis, inflammation, and atherosclerosis.
Endocrinology, , pp. Lyon, R. Law, W. Adiposity, inflammation and atherogenesis. Pittas, N. Joseph, A. J Clin Endocrinol Metabol, 89 , pp. Fletcher, G. Balady, S. Blair, J. Blumenthal, C. Caspersen, B. Chaitman, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans.
Circulation, 94 , pp. Thompson, D. Buchner, I. Balady, M. Williams, B. Marcus, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. A statement from the Council on Clinical Cardiology subcommittee on exercise, rehabilitation, and prevention and the Council on Nutrition, Physical Activity, and Metabolism subcommittee on physical activity. Grundy, B. Brewer, J. Cleeman, S. Smith, C. Definition of metabolic syndrome.
C6 Medline. Position statement.
0コメント